Neuroepidemiology
Original Paper
Frequency and Determinants for Hemorrhagic Transformation of Cerebral InfarctionTerruso V.a · D’Amelio M.a · Di Benedetto N.a · Lupo I.a · Saia V.a · Famoso G.a · Mazzola M.A.a · Aridon P.a · Sarno C.b · Ragonese P.a · Savettieri G.aaDipartimento di Neuroscienze Cliniche, Università degli Studi di Palermo, and bDipartimento di Biotecnologie Mediche e Medicina Legale, Palermo, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: May 01, 2009
Accepted: May 27, 2009
Published online: July 27, 2009
Issue release date: October 2009
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2
ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)
For additional information: https://www.karger.com/NED
Abstract
Background: Frequency and associated risk factors for hemorrhagic transformation (HT), a worrying complication of ischemic stroke (IS), are not clearly defined. Our aim was to estimate the overall frequency and risk factors for HT in a hospital-based population. Methods: A retrospective review of medical records of patients discharged from our department during the period 2004–2006 with a diagnosis of anterior IS. Demographic, clinical and hematological information was collected. Uni- and multivariate logistic regression analyses were used to estimate risk for spontaneous HT. Results: We included 240 patients (125 males, 52%), mean age at admission was 72.5 years. HT was observed in 29 patients (12%). At univariate analysis, consciousness impairment at admission (OR 5.6, 95% CI 1.3–28.2), the presence of early CT signs (OR 2.4, 95% CI 1.1–5.3), infarcts of medium-large size (OR 11.3, 95% CI 4.1–30.8), cardioembolic stroke (OR 2.3, 95% CI 1.1–5.2) and low total cholesterol levels (OR 3.3, 95% CI 1.3–8.2) were significantly associated with HT. At multivariate analysis, only infarct size (OR 10.2, 95% CI 3.2–32.1) was still significantly associated with HT. Conclusions: Frequency of HT in our study was 12%. Consistently with previous results, HT was associated with the size of ischemic area. As patients included in our study did not receive thrombolytic therapy, our results are applicable to those patients whom clinicians, working in a hospital setting, usually deal with.
© 2009 S. Karger AG, Basel
Related Articles:
References
- Lindley RI, Wardlaw JM, Sandercock PA, Rimdusid P, Lewis SC, Signorini DF, Ricci S: Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction. J Stroke Cerebrovasc Dis 2004;13:235–246.
-
Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA: Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;28:1151–1158.
External Resources
- Toni D, Fiorelli M, Bastianello S, Sacchetti ML, Sette G, Argentino C, Montinaro E, Bozzao L: Hemorrhagic transformation of brain infarcts: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996;46:341–345.
- Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh III EE, and the TOAST Investigators: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41.
- Brott T, Marler JR, Olinger CP, Adams HP, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M: Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 1989;20:871–875.
- Bryan RN, Levy LM, Whitlow WD, Killian JM, Preziosi TJ, Rosario JA: Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. Am J Neuroradiol 1991;12:611–620.
- Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W: Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 1993;24:465–468.
- Lodder J: CT-detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift. Acta Neurol Scand 1984;70:329–335.
- Hornig CR, Dorndorf W, Agnoli AL: Hemorrhagic cerebral infarction – a prospective study. Stroke 1986;17:179–185.
- Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, Fujishima M, Omae T: Hemorrhagic transformation in cerebral embolism. Stroke 1989;20:598–603.
- Bozzao L, Angeloni U, Bastianello S, Fantozzi LM, Pierallini A, Fieschi C: Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. Am J Neuroradiol 1991;12:1115–1121.
- Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J: Computed tomographic-angiographic findings within the first five hours of cerebral infarction. Stroke 1991;22:1245–1253.
- Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J: Clinical-radiographic correlations within the first five hours of cerebral infarction. Acta Neurol Scand 1992;86:207–214.
- Alexandrov AV, Black SE, Ehrlich LE, Caldwell CB, Norris JW: Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulant in patients with acute ischemic stroke. Stroke 1997;28:1198–1202.
- Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, Alvarez-Sabin J: Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001;32:1079–1084.
- Montaner J, Alvarez-Sabin J, Molina CA, Angles A, Abilleira S, Arenillas J, Monasterio J: Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 2001;32:2762–2767.
- Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Davalos A: Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003;34:40–46.
- Rodríguez-Yánez M, Castellanos M, Blanco M, Millán M, Nombela F, Sobrino T, Lizasoain I, Leira R, Serena J, Dávalos A, Castillo J: Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 2006;67:1172–1177.
- Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P, Silvestrelli G: Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008;39:2249–2256.
- Fisher M, Adams RD: Observations on brain embolism with special reference to mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951;10:92–94.
- Lodder J, Krijne-Kubat B, Broekman J: Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke 1986;17:626–629.
- Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904–910.
- Eastern Stroke and Coronary Heart Disease Collaborative Research Group: Blood pressure, cholesterol and stroke in eastern Asia. Lancet 1998;352:1801–1807.
- Giroud M, Creisson E, Fayolle H, Andre N, Becker F, Martin D, Dumas R: Risk factors for primary cerebral hemorrhage: a population-based study – the stroke registry of Dijon. Neuroepidemiology 1995;14:20–26.
- Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, Buck B, Ali L, Restrepo L, Vinuela F, Duckwiler G, Jahan R, Razinia T, Ovbiagele B: Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68:737–742.
- Kim BJ, Lee SH, Ryu WS, Kang BS, Kim CK, Yoon BW: Low level of low-density lipoprotein cholesterol increase hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009;40:1627–1632.
Article / Publication Details
Received: May 01, 2009
Accepted: May 27, 2009
Published online: July 27, 2009
Issue release date: October 2009
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2
ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)
For additional information: https://www.karger.com/NED
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission